Total Payments
$37,295
2024 Payments
$10,182
Companies
9
Transactions
31
Medicare Patients
512
Medicare Billing
$76,105
Payment Breakdown by Category
Consulting$21,847 (58.6%)
Other$7,140 (19.1%)
Research$6,940 (18.6%)
Travel$758.46 (2.0%)
Food & Beverage$609.14 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $21,847 | 7 | 58.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,140 | 6 | 19.1% |
| Unspecified | $6,940 | 4 | 18.6% |
| Travel and Lodging | $758.46 | 6 | 2.0% |
| Food and Beverage | $609.14 | 8 | 1.6% |
Payments by Type
General
$30,355
27 transactions
Research
$6,940
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $14,080 | 10 | $0 (2023) |
| Amgen Inc. | $10,032 | 2 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $6,259 | 12 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $4,275 | 2 | $0 (2022) |
| Mallinckrodt Hospital Products Inc. | $1,920 | 1 | $0 (2021) |
| AbbVie Inc. | $400.00 | 1 | $0 (2020) |
| SOBI, INC | $150.00 | 1 | $0 (2024) |
| UCB, Inc. | $131.32 | 1 | $0 (2023) |
| Celltrion USA Inc. | $47.38 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,182 | 3 | Amgen Inc. ($10,032) |
| 2023 | $4,319 | 4 | PFIZER INC. ($4,140) |
| 2022 | $4,275 | 2 | E.R. Squibb & Sons, L.L.C. ($4,275) |
| 2021 | $1,920 | 1 | Mallinckrodt Hospital Products Inc. ($1,920) |
| 2020 | $3,200 | 3 | PFIZER INC. ($2,800) |
| 2019 | $5,870 | 4 | PFIZER INC. ($5,870) |
| 2018 | $7,529 | 14 | Regeneron Pharmaceuticals, Inc. ($6,259) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | SOBI, INC | Gamifant (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Hematology | ||||||
| 02/14/2024 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $3,040.00 | General |
| 02/09/2024 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $6,992.00 | General |
| 11/14/2023 | Celltrion USA Inc. | YUFLYMA (Biological) | Food and Beverage | In-kind items and services | $47.38 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2023 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $131.32 | General |
| Category: Immunology | ||||||
| 11/02/2023 | PFIZER INC. | VYNDAQEL (Drug) | — | In-kind items and services | $940.00 | Research |
| Study: TAFAMIDIS MEGLUMINE CLINICAL PUBLICATION PROGRAM • Category: CARDIOVASCULAR | ||||||
| 08/04/2023 | PFIZER INC. | XELJANZ (Drug) | — | In-kind items and services | $3,200.00 | Research |
| Study: TOFACITINIB CLINICAL PUBLICATION PROGRAM • Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 04/01/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Consulting Fee | Cash or cash equivalent | $3,150.00 | General |
| Category: Oncology | ||||||
| 02/16/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| Category: Oncology | ||||||
| 12/15/2021 | Mallinckrodt Hospital Products Inc. | CELLEX (Device) | Consulting Fee | Cash or cash equivalent | $1,920.00 | General |
| Category: CRITICAL CARE | ||||||
| 07/17/2020 | AbbVie Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 07/02/2020 | PFIZER INC. | XELJANZ (Drug) | — | In-kind items and services | $1,400.00 | Research |
| Study: TOFACITINIB CLINICAL PUBLICATION PROGRAM • Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 04/23/2020 | PFIZER INC. | XELJANZ (Drug) | — | In-kind items and services | $1,400.00 | Research |
| Study: TOFACITINIB CLINICAL PUBLICATION PROGRAM • Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/13/2019 | PFIZER INC. | XELJANZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $940.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/16/2019 | PFIZER INC. | XELJANZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,400.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/02/2019 | PFIZER INC. | XELJANZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $3,200.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/31/2019 | PFIZER INC. | XELJANZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $330.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/24/2018 | PFIZER INC. | XELJANZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $940.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/05/2018 | PFIZER INC. | XELJANZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $330.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/31/2018 | Regeneron Pharmaceuticals, Inc. | KEVZARA SARILUMAB INJECTION (Biological) | Travel and Lodging | In-kind items and services | $159.85 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/31/2018 | Regeneron Pharmaceuticals, Inc. | KEVZARA SARILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $106.31 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/31/2018 | Regeneron Pharmaceuticals, Inc. | KEVZARA SARILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $67.11 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/31/2018 | Regeneron Pharmaceuticals, Inc. | KEVZARA SARILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $54.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/31/2018 | Regeneron Pharmaceuticals, Inc. | KEVZARA SARILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $43.49 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/15/2018 | Regeneron Pharmaceuticals, Inc. | KEVZARA SARILUMAB INJECTION (Biological) | Consulting Fee | Cash or cash equivalent | $5,220.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| TOFACITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $6,000 | 3 |
| TAFAMIDIS MEGLUMINE CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $940.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 178 | 186 | $60,525 | $20,034 |
| 2022 | 4 | 145 | 201 | $72,845 | $23,675 |
| 2021 | 3 | 110 | 172 | $60,185 | $21,290 |
| 2020 | 3 | 79 | 104 | $36,194 | $11,107 |
Total Patients
512
Total Services
663
Medicare Billing
$76,105
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 58 | $16,762 | $4,732 | 28.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 37 | 39 | $12,480 | $4,614 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 42 | 45 | $9,945 | $3,721 | 37.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $8,490 | $2,794 | 32.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 16 | $6,576 | $2,295 | 34.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 13 | 13 | $6,272 | $1,878 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 132 | $38,148 | $12,598 | 33.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 36 | 36 | $20,016 | $6,410 | 32.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 18 | 21 | $8,169 | $2,651 | 32.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $6,512 | $2,017 | 31.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 119 | $34,391 | $11,985 | 34.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 31 | 31 | $17,236 | $6,042 | 35.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 22 | $8,558 | $3,262 | 38.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 44 | 66 | $19,074 | $5,993 | 31.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 21 | 24 | $9,336 | $2,716 | 29.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 14 | 14 | $7,784 | $2,398 | 30.8% |
About Dr. Laura Cappelli, M.D
Dr. Laura Cappelli, M.D is a Rheumatology healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1225273840.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Cappelli, M.D has received a total of $37,295 in payments from pharmaceutical and medical device companies, with $10,182 received in 2024. These payments were reported across 31 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($21,847).
As a Medicare-enrolled provider, Cappelli has provided services to 512 Medicare beneficiaries, totaling 663 services with total Medicare billing of $76,105. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Baltimore, MD
- Active Since 12/10/2008
- Last Updated 10/19/2016
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225273840
Products in Payments
- XELJANZ (Drug) $13,140
- KEVZARA SARILUMAB INJECTION (Biological) $6,259
- OPDIVO (Biological) $4,275
- CELLEX (Device) $1,920
- VYNDAQEL (Drug) $940.00
- Gamifant (Drug) $150.00
- Bimzelx (Biological) $131.32
- YUFLYMA (Biological) $47.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Baltimore
Michelle Petri, M.d, M.D
Rheumatology — Payments: $402,963
Rheumatology $402,963
Dr. Marc Hochberg, M.d, M.D
Rheumatology — Payments: $193,354
Rheumatology $193,354
Clifton Bingham
Rheumatology — Payments: $186,032
Rheumatology $186,032
Dr. Philip Seo, Md, Mhs, MD, MHS
Rheumatology — Payments: $109,386
Rheumatology $109,386
Thomas Grader-Beck, M.d, M.D
Rheumatology — Payments: $100,607
Rheumatology $100,607
Lisa Christopher, M.d, M.D
Rheumatology — Payments: $95,869
Rheumatology $95,869